DocGo (NASDAQ:DCGO – Get Free Report) is anticipated to announce its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect the company to post earnings of ($0.1075) per share and revenue of $77.24 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Monday, November 9, 2026 at 5:00 PM ET.
DocGo (NASDAQ:DCGO – Get Free Report) last released its quarterly earnings data on Monday, August 17th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The company had revenue of $73.42 million for the quarter, compared to analysts’ expectations of $75.35 million. DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. On average, analysts expect DocGo to post ($0.22) EPS for the current fiscal year and ($0.06) EPS for the next fiscal year.
DocGo Trading Up 2.1%
Shares of DocGo stock opened at $0.25 on Monday. DocGo has a 12-month low of $0.24 and a 12-month high of $1.17. The company has a market cap of $24.93 million, a P/E ratio of -0.13 and a beta of 1.03. The company’s fifty day simple moving average is $0.35 and its two-hundred day simple moving average is $0.57.
Wall Street Analyst Weigh In
Several brokerages have issued reports on DCGO. Canaccord Genuity Group reissued a “hold” rating and issued a $1.00 target price on shares of DocGo in a research report on Tuesday, August 18th. Weiss Ratings restated a “sell (e+)” rating on shares of DocGo in a report on Monday, September 14th. Finally, Needham & Company LLC reaffirmed a “buy” rating on shares of DocGo in a report on Wednesday, September 30th. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $2.17.
Read Our Latest Research Report on DocGo
About DocGo
DocGo Inc (NASDAQ:DCGO) is a healthcare services company that delivers medical care and related support outside traditional healthcare facilities. Its platform combines mobile medical services, technology and logistics to help healthcare providers, government agencies and other organizations improve access to care.
The company provides mobile health services that can include in-home and community-based clinical care, preventive services, diagnostic testing, vaccinations and care coordination.
Featured Stories
- Five stocks we like better than DocGo
- Uranium Prices Are Near Historic Highs—So Why Hasn’t Cameco Followed?
- Royal Caribbean Buys the Beach as Norwegian Fixes the Ship
- SK hynix Says Memory Demand Beats Supply Through 2030—What It Means for Micron and SanDisk
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
